Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Deals of the day-Mergers and acquisitions
What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war?
Novo Nordisk falls after Metsera shareholders vote for Pfizer's offer
Novo Nordisk falls after Metsera shareholders vote for Pfizer's offer
Metsera shareholders vote for up to $10 billion acquisition by Pfizer (updated)
Metsera shareholders vote for $10 billion acquisition by Pfizer
Analysis: Novo Nordisk CEO signals new appetite for risk in obesity deals
Deals of the day-Mergers and acquisitions
Newscasts - Novo Nordisk shares rise on investor relief after it exits Metsera bid
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Pfizer CEO Albert Bourla Says Think Co Will Pay Entire CVR For Metsera - CNBC Interview
Metsera falls after accepting $10 billion buyout offer from Pfizer (updated)
Pfizer’s obesity win is new formula for pharma M&A